当前位置: 首页 > 期刊 > 《特别健康.下半月》 > 2019年第5期
编号:13342781
长链非编码RNA—LINC01772对肝细胞肝癌预后的影响(2)
http://www.100md.com 2019年5月1日 《特别健康·下半月》 2019年第5期
     [2] Omata M, Cheng A L, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update[J]. Hepatology International, 2017, 11(4):1-54.

    [3] Shen P, Pichler M, Chen M, et al. To Wnt or Lose: The Missing Non-Coding Linc in Colorectal Cancer[J]. International Journal of Molecular Sciences, 2017, 18(9):2003.

    [4] Jemal A, Bray F, Center MM, et al. Global cancer statistics.[J]. Ca A Cancer Journal for Clinicians, 2015, 61(2):69-90.

    [5] Stefano, Colagrande, Andrea, et al. challenges of advanced hepatocellular carcinoma[J]. 世界胃腸病学杂志:英文版, 2016, 22(34):7645-7659.

    [6] Batista P, Chang H. Long Noncoding RNAs: Cellular Address Codes in Development and Disease[J]. Cell, 2013, 152(6):1298-1307.

    [7] Redis R S, Sieuwerts A M, Look M P, et al. CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations[J]. Oncotarget, 2013, 4(10):1748-1762.

    [8] Gutschner T, Hmmerle M, Eimann M, et al. The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells[J]. Cancer Research, 2013, 73(3):1180-1189.

    [9] Qian Liu, Jianguo Huang, Nanjiang Zhou, et al. LncRNA loc285194 is a p53-regulated tumor suppressor[J]. Nucleic Acids Research, 2013, 41(9):4976-4987.

    [10] 张德慧, 严雨姮. 长链非编码RNA LINC01772在肝细胞肝癌中的表达及临床意义[J]. 健康必读, 2018(36).120., 百拇医药(袁新 王锃涵 余祖江)
上一页1 2